Patent litigation has long been a battlefront for technology-focused companies, but it has begun its expansion into the cannabis field. Last summer, in the first case of its kind, United Cannabis Corporation (“UCANN”) sued Pure Hemp Collective Inc., for patent infringement.
UCANN, a publicly-traded biotechnology company headquartered in Golden, Colo., specializes in the development, distribution, licensing, and sales of medical cannabis products for the U.S. and Australian markets. Pure Hemp is a privately-held company located in Conifer, Colo., that manufactures and retails cannabis-based wellness products online and through distributors across the U.S.
This case highlights the growing competition between cannabis companies and the ways by which at least one company is seeking to gain an edge over its competitors.
While this case is still in its infancy, with the continuing proliferation of concentrated cannabis products and producers in the market, the ramifications of the case could extend far beyond a spat between the two Colorado companies: Sales of products containing 95 percent cannabis extracts are now widespread and growing throughout the country.